This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Ronald L. Smith
Introduction
Ronald L. Smith is a notable inventor based in Yardley, PA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in gastrointestinal-targeted therapies. His innovative work has led to the development of a unique process that enhances the delivery of therapeutic agents.
Latest Patents
Smith holds a patent for a process titled "Process for preparing formulations for gastrointestinal-targeted therapies." This invention provides a method for preparing enterically-coated lyospheres that contain therapeutic agents. The process involves providing lyospheres, coating them with an enteric polymer, and isolating the coated lyospheres. The dosage forms created through this process can deliver various therapeutic agents, including polypeptides, proteins, peptides, and more, effectively targeting the ileum, ileo-caecal junction, and colon after oral administration.
Career Highlights
Ronald L. Smith is associated with Merck Sharp & Dohme Corporation, where he has contributed to advancements in pharmaceutical technology. His work focuses on improving drug delivery systems, which are crucial for enhancing patient outcomes in gastrointestinal therapies.
Collaborations
Smith has collaborated with esteemed colleagues, including Akhilesh Bhambhani and Robert K. Evans. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Ronald L. Smith's contributions to the development of gastrointestinal-targeted therapies exemplify the impact of innovative thinking in the pharmaceutical industry. His patent and collaborative efforts continue to influence advancements in drug delivery systems, ultimately benefiting patients in need of effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
